Greenland Mines Ltd. (GRML)
3.23
+0.08
(+2.54%)
USD |
NASDAQ |
Sep 14, 10:38
Greenland Mines Enterprise Value : 0.9612M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.9612M |
| September 10, 2026 | 3.090M |
| September 09, 2026 | 4.265M |
| September 08, 2026 | 4.774M |
| September 04, 2026 | 6.076M |
| September 03, 2026 | 5.187M |
| September 02, 2026 | 6.426M |
| September 01, 2026 | 5.727M |
| August 31, 2026 | 6.362M |
| August 28, 2026 | 6.457M |
| August 27, 2026 | 7.665M |
| August 26, 2026 | 6.966M |
| August 25, 2026 | 21.80M |
| August 24, 2026 | 18.12M |
| August 21, 2026 | 23.15M |
| August 20, 2026 | 17.32M |
| August 19, 2026 | 23.76M |
| August 18, 2026 | 20.82M |
| August 17, 2026 | 22.60M |
| August 14, 2026 | 23.25M |
| August 13, 2026 | 23.41M |
| August 12, 2026 | 23.41M |
| August 11, 2026 | 24.15M |
| August 10, 2026 | 22.72M |
| August 07, 2026 | 21.77M |
| Date | Value |
|---|---|
| August 06, 2026 | 20.02M |
| August 05, 2026 | 21.02M |
| August 04, 2026 | 21.68M |
| August 03, 2026 | 22.90M |
| July 31, 2026 | 21.74M |
| July 30, 2026 | 22.10M |
| July 29, 2026 | 21.14M |
| July 28, 2026 | 22.53M |
| July 27, 2026 | 21.33M |
| July 24, 2026 | 21.55M |
| July 23, 2026 | 22.80M |
| July 22, 2026 | 26.28M |
| July 21, 2026 | 29.87M |
| July 20, 2026 | 20.60M |
| July 17, 2026 | 24.17M |
| July 16, 2026 | 18.58M |
| July 15, 2026 | 19.83M |
| July 14, 2026 | 19.56M |
| July 13, 2026 | 24.31M |
| July 10, 2026 | 29.86M |
| July 09, 2026 | 29.38M |
| July 08, 2026 | 27.41M |
| July 07, 2026 | 28.87M |
| July 06, 2026 | 30.54M |
| July 02, 2026 | 27.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -58.55M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 7.206M |
| Century Therapeutics, Inc. | 269.22M |
| Absci Corp. | 1.211B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.685M |
| Total Expenses (Quarterly) | 3.685M |
| EPS Diluted (Quarterly) | -1.456 |
| Earnings Yield | -377.7% |
| Normalized Earnings Yield | -333.45 |